SAN DIEGO, May 2, 2017 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) announced today that management will present at the 2017 Bank of America Merrill Lynch Healthcare Conference on Tuesday, May 16th, at 4:20 PM PDT (7:20 PM EDT).
Investors, analysts, and the general public are invited to listen to the presentation via webcast, which can be accessed on the "Investors" section of the Orexigen web site at www.orexigen.com. The webcast will be archived and available for replay for 14 days following the call.
Orexigen Investor Contact:Jason Keyes, Chief Financial Officer+1-858- 875-8600 [email protected]
Orexigen Media Contact:Erika HackmannY&R+1-917-538-3375 [email protected]
Advertisement
Investors, analysts, and the general public are invited to listen to the presentation via webcast, which can be accessed on the "Investors" section of the Orexigen web site at www.orexigen.com. The webcast will be archived and available for replay for 14 days following the call.
Advertisement
Orexigen Investor Contact:Jason Keyes, Chief Financial Officer+1-858- 875-8600 [email protected]
Orexigen Media Contact:Erika HackmannY&R+1-917-538-3375 [email protected]
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/orexigen-therapeutics-to-provide-business-update-at-the-2017-bank-of-america-merrill-lynch-healthcare-conference-300450044.html
SOURCE Orexigen Therapeutics, Inc.
